Mei Zhu

Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells

Jia Wei, Baorui Liu, Lixia Yu, 2021, OncoTargets and therapy.

Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

Jia Wei, Baorui Liu, Lifeng Wang, 2021, Journal for ImmunoTherapy of Cancer.

Evaluation of PD-1 blockade using a multicellular tumor spheroid model.

Jia Wei, Baorui Liu, Qiuping Xu, 2019, American journal of translational research.

TTN-AS1 delivered by gastric cancer cell–derived exosome induces gastric cancer progression through in vivo and in vitro studies

Yu Wang, R. Jiang, Yanfang Li, 2022, Cell Biology and Toxicology.